The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Gouldstone, Martin John
    Company Director born in November 1966
    Individual (6 offsprings)
    Officer
    2020-08-27 ~ now
    OF - Director → CIF 0
  • 2
    Moavenian, Arash, Dr
    Company Director born in January 1987
    Individual (3 offsprings)
    Officer
    2020-08-27 ~ now
    OF - Director → CIF 0
  • 3
    THE FURLONG RESEARCH CHARITABLE FOUNDATION - 2011-08-15
    Furlong House, Chandos Street, London, England
    Active Corporate (6 parents, 1 offspring)
    Person with significant control
    2020-08-27 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

NOVARA THERAPEUTICS LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Debtors
198 GBP2024-03-31
198 GBP2023-03-31
Current Assets
198 GBP2024-03-31
198 GBP2023-03-31
Net Current Assets/Liabilities
-28,818 GBP2024-03-31
-26,934 GBP2023-03-31
Total Assets Less Current Liabilities
-28,818 GBP2024-03-31
-26,934 GBP2023-03-31
Net Assets/Liabilities
-28,818 GBP2024-03-31
-26,934 GBP2023-03-31
Equity
Called up share capital
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
-28,918 GBP2024-03-31
-27,034 GBP2023-03-31
Amounts owed to group undertakings
Current
27,480 GBP2024-03-31
25,596 GBP2023-03-31

  • NOVARA THERAPEUTICS LIMITED
    Info
    Registered number 12841228
    Furlong House, 10a Chandos Street, London W1G 9DQ
    Private Limited Company incorporated on 2020-08-27 (4 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.